Available Guidance and Best Practices for Conducting Forced Degradation Studies

Published on: 
, , , , ,
Pharmaceutical Technology, Pharmaceutical Technology-02-02-2002, Volume 26, Issue 2

Participants at a Pharmaceutical Research and Manufacturers of America workshop share their views about the acceptable analytical practices of conducting forced degradation studies.

Related Content:

Regulatory/GMP ComplianceQuality SystemsRegulatory Authority ActionsPharmaceutical Technology-02-02-2002
Confidentially Agreement Signed Between European Union and Republic of Korea Regulatory Bodies
FDA Reports on Status of Postmarketing Requirements and Postmarketing Commitments
Novartis’ Radioligand Therapy Gains FDA Nod for Pediatric Patients